Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
AUD/USD
0.6612
+0.0040
(+0.61%)
OIL
77.99
-0.96
(-1.22%)
GOLD
2,310.10
+0.50
(+0.02%)
Bitcoin AUD
96,486.08
-447.63
(-0.46%)
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
133.66
+3.03
(+2.32%)
At close: 04:00PM EDT
134.90
+1.24
(+0.93%)
After hours:
06:01PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,403,300
1,243,336
933,013
701,887
540,099
Cost of revenue
165,885
150,343
139,989
97,049
63,382
Gross profit
1,237,415
1,092,993
793,024
604,838
476,717
Operating expenses
Research development
832,104
877,387
877,090
771,182
722,343
Selling general and administrative
498,160
481,871
451,421
282,660
317,875
Total operating expenses
1,332,246
1,360,817
1,329,225
1,054,548
1,040,880
Operating income or loss
-94,831
-267,824
-536,201
-449,710
-564,163
Interest expense
19,853
22,010
53,248
63,525
59,947
Total other income/expenses net
62,193
-316,233
-128,237
93,776
68,075
Income before tax
34,060
-520,098
-689,963
-418,948
-553,065
Income tax expense
17,163
15,879
13,525
-168
1,063
Income from continuing operations
16,897
-535,977
-703,488
-418,780
-554,128
Net income
16,897
-535,977
-703,488
-418,780
-554,128
Net income available to common shareholders
16,897
-535,977
-703,488
-418,780
-554,128
Basic EPS
-7.80
-5.80
-8.03
-5.15
-7.11
Diluted EPS
-7.80
-5.80
-8.03
-5.15
-7.11
Basic average shares
88,417
92,398
87,559
81,262
77,956
Diluted average shares
88,417
92,398
87,559
81,262
77,956
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.